Kura Oncology
KURA
$20.59
Share price
1.53%
Change (1 day)
101.67%
Change (1 year)
Categories
Kura Oncology (KURA) - Cash on Hand
Cash on Hand as of December 2023 : $0.42 B
According to Kura Oncology
's latest financial reports the company has $0.42 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kura Oncology - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | -3.2% |
| 2022-12-31 | $0.43 B | -15.44% |
| 2021-12-31 | $0.51 B | -18.22% |
| 2020-12-31 | $0.63 B | 167.35% |
| 2019-12-31 | $0.23 B | 32.35% |
| 2018-12-31 | $0.17 B | 92.16% |
| 2017-12-31 | $93.14 M | 37.4% |
| 2016-12-31 | $67.79 M | -20.94% |
| 2015-12-31 | $85.74 M | 7528.65% |
| 2014-12-31 | $1.12 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -50.89% | 🇺🇸 USA |